U.S. License Holder:
EMD Serono
Date of License:
March-25-2004
Last Update:
July-15-2025
FDA-Approved Indications
GONAL-F RFF (follitropin alfa for injection) is indicated for:
The induction of ovulation and pregnancy in the oligo-anovulatory infertile patient in whom the cause of infertility is functional and not due to primary ovarian failure;
Development of multiple follicles in ovulatory infertile women as part of Assisted Reproductive Technology (ART) cycles.